MINI FUTURE LONG - AMGEN | Delayed Deutsche Boerse AG 09:20:55 27/06/2024 BST | ||
| 11.64 EUR | -0.77% |
|
| Current month | +7.81% | ||
| 1 month | +6.73% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 27/06/24 | 11.64 | -0.77% |
| 26/06/24 | 11.73 | -4.63% |
| 25/06/24 | 12.3 | +2.24% |
| 24/06/24 | 12.03 | +5.34% |
| 21/06/24 | 11.42 | +0.26% |
Delayed Quote Deutsche Boerse AG
Last update June 27, 2024 at 09:20 am
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PZ9M5T |
| ISIN | DE000PZ9M5T5 |
| Date issued | 18/07/2019 |
| Strike | 188 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.43 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.33 € |
|---|---|
| Lowest since issue | 1.09 € |
| Spread | 0.2 € |
| Spread % | 1.69% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.8
USD
Average target price
316.4
USD
Spread / Average Target
+1.16%
- Stock Market
- Certificates
- Certificat
